KZR
Kezar Life Sciences Inc
NASDAQ: KZR · HEALTHCARE · BIOTECHNOLOGY
$7.31
+0.14% today
Updated 2026-04-30
Market cap
$53.59M
P/E ratio
—
P/S ratio
6.03x
EPS (TTM)
$-7.66
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Kezar Life Sciences Inc (KZR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-59.90%
ROA
-29.50%
Debt/equity
0.12x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-8.99M | — | — | — |
| 2017 | $0.00 | $-8.52M | — | — | — |
| 2018 | $0.00 | $-23.17M | — | — | — |
| 2019 | $0.00 | $-31.53M | — | — | — |
| 2020 | $0.00 | $-38.99M | — | — | — |
| 2021 | $0.00 | $-54.63M | — | — | — |
| 2022 | $0.00 | $-65.32M | — | — | — |
| 2023 | $7.00M | $-101.87M | 100.00% | -1,591.77% | -1,455.29% |
| 2024 | $0.00 | $-83.74M | — | — | — |
| 2025 | $0.00 | $-56.03M | — | — | — |